Australian National Enterovirus Reference Laboratory annual report, 2024

Authors

  • Dr Matthew B Kaye National Enterovirus Reference Laboratory, Victorian Infectious Diseases Reference Laboratory, Locked Bag 815, Carlton South VIC 3053
  • Ms Linda K Hobday National Enterovirus Reference Laboratory, Victorian Infectious Diseases Reference Laboratory, Doherty Institute, 792 Elizabeth St, Melbourne 3000, Victoria, Australia
  • Dr Leesa Bruggink National Enterovirus Reference Laboratory, Victorian Infectious Diseases Reference Laboratory, Doherty Institute, 792 Elizabeth St, Melbourne 3000, Victoria, Australia
  • Jade McKenzie National Enterovirus Reference Laboratory, Victorian Infectious Diseases Reference Laboratory, Doherty Institute, 792 Elizabeth St, Melbourne 3000, Victoria, Australia
  • Dr Yi Nong National Enterovirus Reference Laboratory, Victorian Infectious Diseases Reference Laboratory, Doherty Institute, 792 Elizabeth St, Melbourne 3000, Victoria, Australia
  • Dr Bruce R Thorley National Enterovirus Reference Laboratory, Victorian Infectious Diseases Reference Laboratory, Doherty Institute, 792 Elizabeth St, Melbourne 3000, Victoria, Australia

DOI:

https://doi.org/10.33321/cdi.2025.49.047

Keywords:

poliovirus, acute flaccid paralysis, surveillance, enterovirus, poliomyelitis, eradication, vaccination

Abstract

Having been declared polio-free by the World Health Organization (WHO) in 2000, Australia remains at risk of poliovirus importation until the virus is eradicated globally. Australia monitors for poliovirus by conducting surveillance for cases of acute flaccid paralysis (AFP) in children less than 15 years of age, as recommended by the WHO. Cases of AFP in children are notified to the Australian Paediatric Surveillance Unit or the Paediatric Active Enhanced Disease Surveillance System, and faecal specimens are referred for virological investigation to the National Enterovirus Reference Laboratory. In 2024, no cases of poliomyelitis were reported from clinical surveillance and Australia reported 2.04 non-polio AFP cases per 100,000 children, thereby meeting the WHO’s performance criterion for a sensitive surveillance system. Non-polio enteroviruses including enterovirus A71 were identified from clinical specimens collected from 14 AFP cases. Australia also performs enterovirus and wastewater surveillance to complement the clinical surveillance system focussed on children. In 2024, there were 21 different non-polio enterovirus types detected in 764 clinical specimens referred for enterovirus typing, while an ambiguous vaccine-derived poliovirus type 2 was detected through wastewater surveillance. In 2024, there were 99 cases of wild poliovirus reported from the two remaining endemic countries, Afghanistan and Pakistan. Another 319 cases of poliomyelitis due to circulating vaccine-derived poliovirus were reported across 21 countries.

Downloads

Download data is not yet available.

References

Aylward RB. Poliomyelitis. In Heymann DL, ed. Control of Communicable Diseases Manual. 20th ed. Fort Worth: APHA Press, 2015;477–84. doi: https://doi.org/10.2105/CCDM.2745.116.

Nathanson N, Kew OM. From emergence to eradication: the epidemiology of poliomyelitis deconstructed. Am J Epidemiol. 2010;172(11):1213–29. doi: https://doi.org/10.1093/aje/kwq320.

World Health Organization (WHO). Poliomyelitis. [Internet.] Geneva: WHO; 22 October 2024. [Accessed on 31 March 2025.] Available from: https://www.who.int/news-room/fact-sheets/detail/poliomyelitis.

Adams T. Farewell to polio in the Western Pacific. Bull World Health Organ. 2000;78(12):1375.

Australian Paediatric Surveillance Unit (APSU). Study Protocol: Acute Flaccid Paralysis. [Internet.] Sydney: APSU; 2025. [Accessed on 31 March 2025.] Available from: https://www.apsu.org.au/assets/current-studies/AFP-Study-Protocol-June-2.pdf.

Paediatric Active Enhanced Disease Surveillance (PAEDS). Surveillance and research: acute flaccid paralysis. [Internet.] Sydney: National Centre for Immunisation Research and Surveillance, PAEDS; 2025. [Accessed on 31 March 2025.] Available from: http://www.paeds.org.au/our-work/surveillance-and-research-0.

Puenpa J, Wanlapakorn N, Vongpunsawad S, Poovorawan Y. The history of enterovirus A71 outbreaks and molecular epidemiology in the Asia-Pacific region. J Biomed Sci. 2019;26(1):75. doi: https://doi.org/10.1186/s12929-019-0573-2.

Sun J, Hu XY, Yu XF. Current understanding of human enterovirus D68. Viruses. 2019;11(6):490. doi: https://doi.org/10.3390/v11060490.

World Health Organization (WHO). Wild Poliovirus. [Internet.] Geneva: WHO; 2025. [Accessed on 31 March 2025.] Available from: https://polioeradication.org/wild-poliovirus/.

WHO. Global Wild AFP cases and environmental samples 2018–2025. [Webpage.] Geneva: WHO; 9 June 2025. [Accessed on 11 June 2025.] Available from: https://polioeradication.org/wild-poliovirus-count/.

Dattani S, Spooner F, Ochmann S, Roser M. Polio. [Internet.] Oxford: University of Oxford, Global Change Data Lab, Our World in Data; May 2024. [Accessed on 31 March 2025.] Available from: https://ourworldindata.org/polio.

WHO. Global circulating vaccine-derived poliovirus (cVDPV). AFP cases and environmental samples 2021–2025. [Webpage.] Geneva: WHO; 9 June 2025. [Accessed on 11 June 2025.] Available from: https://polioeradication.org/circulating-vaccine-derived-poliovirus-count/.

Australian Government Department of Health, Disability and Ageing. Poliovirus infection. [Internet.] Canberra: Australian Government Department of Health, Disability and Ageing; 12 July 2022. [Accessed on 31 March 2025.] Available from: http://www.health.gov.au/diseases/poliovirus-infection.

Queensland State Government Department of Health (Queensland Health). Acute flaccid paralysis (AFP). [Internet.] Brisbane: Queensland Health; 20 July 2022. [Accessed on 31 March 2025.] Available from: https://www.health.qld.gov.au/disease-control/conditions/acute-flaccid-paralysis-afp.

Australian Paediatric Surveillance Unit (APSU). Current Studies. Acute Flaccid Paralysis (AFP). [Internet.] Sydney: The Children’s Hospital at Westmead, APSU; 2025. [Accessed on 31 March 2025.] Available from: https://apsu.org.au/studies/current/.

WHO. Polio: Vaccine Preventable Diseases Surveillance Standards. Geneva: WHO; 4 September 2018. [Accessed on 31 March 2025.] Available from: https://www.who.int/publications/m/item/vaccine-preventable-diseases-surveillance-standards-polio.

WHO. Weekly Epidemiological Record (WER). [Online journal landing page.] Geneva: WHO; 2025. [Accessed on 31 March 2025.] Available from: https://www.who.int/publications/journals/weekly-epidemiological-record.

Wood DJ, Hull B. L20B cells simplify culture of polioviruses from clinical samples. J Med Virol. 1999;58(2);188–92. doi: https://doi.org/10.1002/(SICI)1096-9071(199906)58:2<188::AID-JMV15>3.0.CO;2-H.

WHO. Polio Laboratory Manual, 4th edition. (WHO/IVB/04.10) Geneva: WHO, Department of Immunization, Vaccines and Biologicals; 2004.

Sun H, Harrington C, Gerloff N, Mandelbaum M, Jeffries-Miles S, Apostol LNG et al Validation of a redesigned pan-poliovirus assay and real-time PCR platforms for the global poliovirus laboratory network. PloS One. 2021;16(8):e0255795. doi: https://doi.org/10.1371/journal.pone.0255795.

Stewardson AJ, Roberts JA, Beckett CL, Prime HT, Loh PS, Thorley BR et al. Imported case of poliomyelitis, Melbourne, Australia, 2007. Emerg Infect Dis. 2009;15(1):63–5. doi: https://doi.org/10.3201/eid1501.080791.

WHO. Guidelines for environmental surveillance of poliovirus circulation. Geneva: WHO, Department of Vaccines and Biologicals; 2003. Available from: https://iris.who.int/handle/10665/67854.

Australian Government Department of Health, Disability and Ageing. PHLN referral pathway for poliovirus confirmatory testing. National referral pathway for the confirmatory testing of poliovirus detected in wastewater. Canberra: Australian Government Department of Health, Disability and Ageing; 1 August 2023. [Accessed on 31 March 2025.] Available from: https://www.health.gov.au/resources/publications/phln-referral-pathway-for-poliovirus-confirmatory-testing.

Roberts JA. Thesis. “Chapter 2: Development of a Novel Enterovirus Detection and Super-Speciation Assay”, An integrated bioinformatics and computational biophysics approach to enterovirus surveillance and research. RMIT University, 2014: 62-109. [Accessed on 26 April 2024.] Available from: https://researchbank.rmit.edu.au/view/rmit:162129.

Raphael M, Adam DC, Chughtai AA, Kelly-Hanku A, Hutchinson D, Lai YA et al. Poliomyelitis outbreak in Papua New Guinea, 2018. Global Biosecurity. 2022;4(1). doi: https://doi.org/10.31646/gbio.164.

Snider CJ, Boualam L, Tallis G, Takashima Y, Abeyasinghe R, Lo YR et al. Concurrent outbreaks of circulating vaccine-derived poliovirus types 1 and 2 affecting the Republic of the Philippines and Malaysia, 2019–2021. Vaccine. 2023;41(Suppl 1):A58–69. doi: https://doi.org/10.1016/j.vaccine.2022.02.022.

World Health Organization (WHO). Polio Affected Countries: Indonesia. [Internet.] Geneva: WHO; 24 March 2025. [Accessed on 31 March 2025.] Available from: https://polioeradication.org/about-polio/where-we-work/.

Downloads

Published

17/12/25

How to Cite

Kaye, Matthew, Linda Hobday, Leesa Bruggink, Jade McKenzie, Yi Nong, and Bruce Thorley. 2025. “Australian National Enterovirus Reference Laboratory Annual Report, 2024”. Communicable Diseases Intelligence 49 (December). https://doi.org/10.33321/cdi.2025.49.047.

Issue

Section

Annual report

Categories